Eliem Therapeutics is a biotechnology company delivering therapies that empower patients to live on their own terms. Locations in US, with R&D operations in Cambridge, UK, Eliem channels its experience, energy, and passion for improving patients’ quality of life by developing and commercializing potentially “best-in-class” drug candidates to treat neuronal excitability disorders. These conditions—such as chronic pain, depression, epilepsy, and anxiety—cause deep suffering for tens of millions of people each day. At its core, the Eliem team is motivated by the promise of helping patients live happier, more fulfilling lives. Eliem is a publicly traded company (NASDAQ: ELYM) Read our community guidelines here: https://eliemtx.com/community-engagement-guidelines/
View Top Employees from Eliem TherapeuticsWebsite | http://www.eliemtx.com |
Ticker | ELYM |
Employees | 30 (30 on RocketReach) |
Founded | 2018 |
Address | 15 Lake Bellevue Dr Suite 101, Bellevue, Washington 98005, US |
Phone | (425) 276-2300 |
Technologies |
JavaScript,
HTML,
PHP
+26 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Drug Discovery, Healthcare, Biotechnology |
SIC | SIC Code 28 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 3254 Companies, NAICS Code 541714 Companies |
Looking for a particular Eliem Therapeutics employee's phone or email?
Bob Azelby is the President and Chief Executive Officer of Eliem Therapeutics.
30 people are employed at Eliem Therapeutics.
Eliem Therapeutics is based in Bellevue, Washington.
The NAICS codes for Eliem Therapeutics are [32, 325, 5417, 54, 54171, 541, 3254, 541714].
The SIC codes for Eliem Therapeutics are [28, 87].